Showing results for all states.
A15 - Respiratory tuberculosis——
A15.0 - Tuberculosis of lung——
A17 - Tuberculosis of nervous system——
A18 - Tuberculosis of other organs——
A18.11 - Tuberculosis of kidney and ureter——
A19 - Miliary tuberculosis——
A19.0 - Acute miliary tuberculosis of a single specified site——
A19.1 - Acute miliary tuberculosis of multiple sites——
A19.2 - Acute miliary tuberculosis, unspecified——
A19.9 - Miliary tuberculosis, unspecified——
A31 - Infection due to other mycobacteria——
B00.81 - Herpesviral hepatitis——
B02 - Zoster [herpes zoster]——
B02.23 - Postherpetic polyneuropathy——
B15 - Acute hepatitis A——
B15.9 - Hepatitis A without hepatic coma——
B16 - Acute hepatitis B——
B16.1 - Acute hepatitis B with delta-agent without hepatic coma——
B16.9 - Acute hepatitis B without delta-agent and without hepatic coma——
B17 - Other acute viral hepatitis——
B17.0 - Acute delta-(super) infection of hepatitis B carrier——
B17.1 - Acute hepatitis C——
B17.10 - Acute hepatitis C without hepatic coma——
B17.2 - Acute hepatitis E——
B17.8 - Other specified acute viral hepatitis——
B17.9 - Acute viral hepatitis, unspecified——
B18 - Chronic viral hepatitis——
B18.0 - Chronic viral hepatitis B with delta-agent——
B18.1 - Chronic viral hepatitis B without delta-agent——
B18.2 - Chronic viral hepatitis C——
B18.8 - Other chronic viral hepatitis——
B18.9 - Chronic viral hepatitis, unspecified——
B19 - Unspecified viral hepatitis——
B19.0 - Unspecified viral hepatitis with hepatic coma——
B19.1 - Unspecified viral hepatitis B——
B19.10 - Unspecified viral hepatitis B without hepatic coma——
B19.11 - Unspecified viral hepatitis B with hepatic coma——
B19.2 - Unspecified viral hepatitis C——
B19.20 - Unspecified viral hepatitis C without hepatic coma——
B19.9 - Unspecified viral hepatitis without hepatic coma——
B25.1 - Cytomegaloviral hepatitis——
B26.81 - Mumps hepatitis——
B58.1 - Toxoplasma hepatitis——
B90 - Sequelae of tuberculosis——
B94.2 - Sequelae of viral hepatitis——
C22 - Malignant neoplasm of liver and intrahepatic bile ducts——
C22.0 - Liver cell carcinoma——
C22.1 - Intrahepatic bile duct carcinoma——
C22.7 - Other specified carcinomas of liver——
C22.8 - Malignant neoplasm of liver, primary, unspecified as to type——
C22.9 - Malignant neoplasm of liver, not specified as primary or secondary——
C24 - Malignant neoplasm of other and unspecified parts of biliary tract——
C24.0 - Malignant neoplasm of extrahepatic bile duct——
C77 - Secondary and unspecified malignant neoplasm of lymph nodes——
C77.8 - Secondary and unspecified malignant neoplasm of lymph nodes of multiple regions——
C77.9 - Secondary and unspecified malignant neoplasm of lymph node, unspecified——
C78.7 - Secondary malignant neoplasm of liver and intrahepatic bile duct——
C81 - Hodgkin lymphoma——
C81.0 - Nodular lymphocyte predominant Hodgkin lymphoma——
C81.00 - Nodular lymphocyte predominant Hodgkin lymphoma, unspecified site——
C81.01 - Nodular lymphocyte predominant Hodgkin lymphoma, lymph nodes of head, face, and neck——
C81.02 - Nodular lymphocyte predominant Hodgkin lymphoma, intrathoracic lymph nodes——
C81.03 - Nodular lymphocyte predominant Hodgkin lymphoma, intra-abdominal lymph nodes——
C81.04 - Nodular lymphocyte predominant Hodgkin lymphoma, lymph nodes of axilla and upper limb——
C81.05 - Nodular lymphocyte predominant Hodgkin lymphoma, lymph nodes of inguinal region and lower limb——
C81.06 - Nodular lymphocyte predominant Hodgkin lymphoma, intrapelvic lymph nodes——
C81.07 - Nodular lymphocyte predominant Hodgkin lymphoma, spleen——
C81.08 - Nodular lymphocyte predominant Hodgkin lymphoma, lymph nodes of multiple sites——
C81.09 - Nodular lymphocyte predominant Hodgkin lymphoma, extranodal and solid organ sites——
C81.1 - Nodular sclerosis Hodgkin lymphoma——
C81.10 - Nodular sclerosis Hodgkin lymphoma, unspecified site——
C81.11 - Nodular sclerosis Hodgkin lymphoma, lymph nodes of head, face, and neck——
C81.12 - Nodular sclerosis Hodgkin lymphoma, intrathoracic lymph nodes——
C81.13 - Nodular sclerosis Hodgkin lymphoma, intra-abdominal lymph nodes——
C81.14 - Nodular sclerosis Hodgkin lymphoma, lymph nodes of axilla and upper limb——
C81.15 - Nodular sclerosis Hodgkin lymphoma, lymph nodes of inguinal region and lower limb——
C81.16 - Nodular sclerosis Hodgkin lymphoma, intrapelvic lymph nodes——
C81.17 - Nodular sclerosis Hodgkin lymphoma, spleen——
C81.18 - Nodular sclerosis Hodgkin lymphoma, lymph nodes of multiple sites——
C81.19 - Nodular sclerosis Hodgkin lymphoma, extranodal and solid organ sites——
C81.2 - Mixed cellularity Hodgkin lymphoma——
C81.20 - Mixed cellularity Hodgkin lymphoma, unspecified site——
C81.21 - Mixed cellularity Hodgkin lymphoma, lymph nodes of head, face, and neck——
C81.22 - Mixed cellularity Hodgkin lymphoma, intrathoracic lymph nodes——
C81.23 - Mixed cellularity Hodgkin lymphoma, intra-abdominal lymph nodes——
C81.24 - Mixed cellularity Hodgkin lymphoma, lymph nodes of axilla and upper limb——
C81.25 - Mixed cellularity Hodgkin lymphoma, lymph nodes of inguinal region and lower limb——
C81.26 - Mixed cellularity Hodgkin lymphoma, intrapelvic lymph nodes——
C81.27 - Mixed cellularity Hodgkin lymphoma, spleen——
C81.28 - Mixed cellularity Hodgkin lymphoma, lymph nodes of multiple sites——
C81.29 - Mixed cellularity Hodgkin lymphoma, extranodal and solid organ sites——
C82 - Follicular lymphoma——
C82.0 - Follicular lymphoma grade I——
C82.00 - Follicular lymphoma grade I, unspecified site——
C82.01 - Follicular lymphoma grade I, lymph nodes of head, face, and neck——
C82.07 - Follicular lymphoma grade I, spleen——
C82.1 - Follicular lymphoma grade II——
C82.10 - Follicular lymphoma grade II, unspecified site——
C82.11 - Follicular lymphoma grade II, lymph nodes of head, face, and neck——
C82.17 - Follicular lymphoma grade II, spleen——
C82.30 - Follicular lymphoma grade IIIa, unspecified site——
C82.31 - Follicular lymphoma grade IIIa, lymph nodes of head, face, and neck——
C82.32 - Follicular lymphoma grade IIIa, intrathoracic lymph nodes——
C82.37 - Follicular lymphoma grade IIIa, spleen——
C82.4 - Follicular lymphoma grade IIIb——
C82.89 - Other types of follicular lymphoma, extranodal and solid organ sites——
C82.90 - Follicular lymphoma, unspecified, unspecified site——
C82.99 - Follicular lymphoma, unspecified, extranodal and solid organ sites——
C83 - Non-follicular lymphoma——
C83.1 - Mantle cell lymphoma——
C83.10 - Mantle cell lymphoma, unspecified site——
C83.11 - Mantle cell lymphoma, lymph nodes of head, face, and neck——
C83.12 - Mantle cell lymphoma, intrathoracic lymph nodes——
C83.13 - Mantle cell lymphoma, intra-abdominal lymph nodes——
C83.14 - Mantle cell lymphoma, lymph nodes of axilla and upper limb——
C83.15 - Mantle cell lymphoma, lymph nodes of inguinal region and lower limb——
C83.16 - Mantle cell lymphoma, intrapelvic lymph nodes——
C83.17 - Mantle cell lymphoma, spleen——
C83.18 - Mantle cell lymphoma, lymph nodes of multiple sites——
C83.19 - Mantle cell lymphoma, extranodal and solid organ sites——
C83.3 - Diffuse large B-cell lymphoma——
C83.30 - Diffuse large B-cell lymphoma, unspecified site——
C83.31 - Diffuse large B-cell lymphoma, lymph nodes of head, face, and neck——
C83.32 - Diffuse large B-cell lymphoma, intrathoracic lymph nodes——
C83.33 - Diffuse large B-cell lymphoma, intra-abdominal lymph nodes——
C83.34 - Diffuse large B-cell lymphoma, lymph nodes of axilla and upper limb——
C83.35 - Diffuse large B-cell lymphoma, lymph nodes of inguinal region and lower limb——
C83.36 - Diffuse large B-cell lymphoma, intrapelvic lymph nodes——
C83.37 - Diffuse large B-cell lymphoma, spleen——
C83.38 - Diffuse large B-cell lymphoma, lymph nodes of multiple sites——
C83.39 - Diffuse large B-cell lymphoma, extranodal and solid organ sites——
C85 - Other specified and unspecified types of non-Hodgkin lymphoma——
C85.8 - Other specified types of non-Hodgkin lymphoma——
C85.80 - Other specified types of non-Hodgkin lymphoma, unspecified site——
C85.86 - Other specified types of non-Hodgkin lymphoma, intrapelvic lymph nodes——
C85.89 - Other specified types of non-Hodgkin lymphoma, extranodal and solid organ sites——
C85.9 - Non-Hodgkin lymphoma, unspecified——
C85.90 - Non-Hodgkin lymphoma, unspecified, unspecified site——
C85.91 - Non-Hodgkin lymphoma, unspecified, lymph nodes of head, face, and neck——
C85.92 - Non-Hodgkin lymphoma, unspecified, intrathoracic lymph nodes——
C85.93 - Non-Hodgkin lymphoma, unspecified, intra-abdominal lymph nodes——
C85.94 - Non-Hodgkin lymphoma, unspecified, lymph nodes of axilla and upper limb——
C85.95 - Non-Hodgkin lymphoma, unspecified, lymph nodes of inguinal region and lower limb——
C85.96 - Non-Hodgkin lymphoma, unspecified, intrapelvic lymph nodes——
C85.97 - Non-Hodgkin lymphoma, unspecified, spleen——
C85.98 - Non-Hodgkin lymphoma, unspecified, lymph nodes of multiple sites——
C85.99 - Non-Hodgkin lymphoma, unspecified, extranodal and solid organ sites——
C88 - Malignant immunoproliferative diseases and certain other B-cell lymphomas——
D01.5 - Carcinoma in situ of liver, gallbladder and bile ducts——
D13 - Benign neoplasm of other and ill-defined parts of digestive system——
D13.4 - Benign neoplasm of liver——
D13.5 - Benign neoplasm of extrahepatic bile ducts——
D37.1 - Neoplasm of uncertain behavior of stomach——
D37.6 - Neoplasm of uncertain behavior of liver, gallbladder and bile ducts——
D37.9 - Neoplasm of uncertain behavior of digestive organ, unspecified——
D63 - Anemia in chronic diseases classified elsewhere——
D63.1 - Anemia in chronic kidney disease——
D69 - Purpura and other hemorrhagic conditions——
D69.3 - Immune thrombocytopenic purpura——
D69.4 - Other primary thrombocytopenia——
D69.6 - Thrombocytopenia, unspecified——
D69.8 - Other specified hemorrhagic conditions——
D89 - Other disorders involving the immune mechanism, not elsewhere classified——
D89.1 - Cryoglobulinemia——
E10.41 - Type 1 diabetes mellitus with diabetic mononeuropathy——
E71.522 - Adrenomyeloneuropathy——
E83.11 - Hemochromatosis——
E83.118 - Other hemochromatosis——
E83.119 - Hemochromatosis, unspecified——
F11 - Opioid related disorders——
F11.1 - Opioid abuse——
F11.10 - Opioid abuse, uncomplicated——
F11.12 - Opioid abuse with intoxication——
F11.2 - Opioid dependence——
F11.20 - Opioid dependence, uncomplicated——
F11.21 - Opioid dependence, in remission——
F11.9 - Opioid use, unspecified——
F11.90 - Opioid use, unspecified, uncomplicated——
F11.92 - Opioid use, unspecified with intoxication——
F12 - Cannabis related disorders——
F12.1 - Cannabis abuse——
F13 - Sedative, hypnotic, or anxiolytic related disorders——
F13.1 - Sedative, hypnotic or anxiolytic-related abuse——
F13.10 - Sedative, hypnotic or anxiolytic abuse, uncomplicated——
F14 - Cocaine related disorders——
F14.1 - Cocaine abuse——
F15 - Other stimulant related disorders——
F15.1 - Other stimulant abuse——
F15.10 - Other stimulant abuse, uncomplicated——
F16 - Hallucinogen related disorders——
F16.1 - Hallucinogen abuse——
F17.2 - Nicotine dependence——
F18 - Inhalant related disorders——
F18.1 - Inhalant abuse——
F18.10 - Inhalant abuse, uncomplicated——
F19 - Other psychoactive substance related disorders——
F19.1 - Other psychoactive substance abuse——
F19.10 - Other psychoactive substance abuse, uncomplicated——
F19.11 - Other psychoactive substance abuse, in remission——
F19.12 - Other psychoactive substance abuse with intoxication——
F19.2 - Other psychoactive substance dependence——
F19.20 - Other psychoactive substance dependence, uncomplicated——
F19.9 - Other psychoactive substance use, unspecified——
F55 - Abuse of non-psychoactive substances——
G58 - Other mononeuropathies——
G58.9 - Mononeuropathy, unspecified——
G60 - Hereditary and idiopathic neuropathy——
G60.0 - Hereditary motor and sensory neuropathy——
G60.3 - Idiopathic progressive neuropathy——
G60.8 - Other hereditary and idiopathic neuropathies——
G61 - Inflammatory polyneuropathy——
G61.1 - Serum neuropathy——
G62 - Other and unspecified polyneuropathies——
G62.9 - Polyneuropathy, unspecified——
G63 - Polyneuropathy in diseases classified elsewhere——
G89 - Pain, not elsewhere classified——
G89.29 - Other chronic pain——
G89.3 - Neoplasm related pain (acute) (chronic)——
G89.4 - Chronic pain syndrome——
G90.0 - Idiopathic peripheral autonomic neuropathy——
G99 - Other disorders of nervous system in diseases classified elsewhere——
G99.0 - Autonomic neuropathy in diseases classified elsewhere——
I12 - Hypertensive chronic kidney disease——
I12.0 - Hypertensive chronic kidney disease with stage 5 chronic kidney disease or end stage renal disease——
I13 - Hypertensive heart and chronic kidney disease——
I77 - Other disorders of arteries and arterioles——
I77.6 - Arteritis, unspecified——
K65 - Peritonitis——
K65.1 - Peritoneal abscess——
K70 - Alcoholic liver disease——
K70.0 - Alcoholic fatty liver——
K70.1 - Alcoholic hepatitis——
K70.10 - Alcoholic hepatitis without ascites——
K70.11 - Alcoholic hepatitis with ascites——
K70.4 - Alcoholic hepatic failure——
K70.9 - Alcoholic liver disease, unspecified——
K71 - Toxic liver disease——
K71.0 - Toxic liver disease with cholestasis——
K71.1 - Toxic liver disease with hepatic necrosis——
K71.2 - Toxic liver disease with acute hepatitis——
K71.3 - Toxic liver disease with chronic persistent hepatitis——
K71.5 - Toxic liver disease with chronic active hepatitis——
K71.9 - Toxic liver disease, unspecified——
K72 - Hepatic failure, not elsewhere classified——
K72.0 - Acute and subacute hepatic failure——
K72.00 - Acute and subacute hepatic failure without coma——
K72.01 - Acute and subacute hepatic failure with coma——
K72.11 - Chronic hepatic failure with coma——
K72.9 - Hepatic failure, unspecified——
K72.90 - Hepatic failure, unspecified without coma——
K72.91 - Hepatic failure, unspecified with coma——
K73 - Chronic hepatitis, not elsewhere classified——
K73.9 - Chronic hepatitis, unspecified——
K74 - Fibrosis and cirrhosis of liver——
K74.0 - Hepatic fibrosis——
K74.6 - Other and unspecified cirrhosis of liver——
K74.60 - Unspecified cirrhosis of liver——
K74.69 - Other cirrhosis of liver——
K75 - Other inflammatory liver diseases——
K75.0 - Abscess of liver——
K75.2 - Nonspecific reactive hepatitis——
K75.4 - Autoimmune hepatitis——
K75.8 - Other specified inflammatory liver diseases——
K75.81 - Nonalcoholic steatohepatitis (NASH)——
K76 - Other diseases of liver——
K76.0 - Fatty (change of) liver, not elsewhere classified——
K76.1 - Chronic passive congestion of liver——
K76.2 - Central hemorrhagic necrosis of liver——
K76.3 - Infarction of liver——
K76.8 - Other specified diseases of liver——
K76.89 - Other specified diseases of liver——
K76.9 - Liver disease, unspecified——
K77 - Liver disorders in diseases classified elsewhere——
L93 - Lupus erythematosus——
L95 - Vasculitis limited to skin, not elsewhere classified——
M05 - Rheumatoid arthritis with rheumatoid factor——
M05.2 - Rheumatoid vasculitis with rheumatoid arthritis——
M05.5 - Rheumatoid polyneuropathy with rheumatoid arthritis——
M13.0 - Polyarthritis, unspecified——
M25.48 - Effusion, other site——
M25.5 - Pain in joint——
M30 - Polyarteritis nodosa and related conditions——
M30.0 - Polyarteritis nodosa——
M30.1 - Polyarteritis with lung involvement [Churg-Strauss]——
M30.8 - Other conditions related to polyarteritis nodosa——
M31 - Other necrotizing vasculopathies——
M31.1 - Thrombotic microangiopathy——
M31.3 - Wegener's granulomatosis——
M31.30 - Wegener's granulomatosis without renal involvement——
M31.31 - Wegener's granulomatosis with renal involvement——
M31.4 - Aortic arch syndrome [Takayasu]——
M32 - Systemic lupus erythematosus (SLE)——
M32.0 - Drug-induced systemic lupus erythematosus——
N00 - Acute nephritic syndrome——
N00.3 - Acute nephritic syndrome with diffuse mesangial proliferative glomerulonephritis——
N00.8 - Acute nephritic syndrome with other morphologic changes——
N00.9 - Acute nephritic syndrome with unspecified morphologic changes——
N01.2 - Rapidly progressive nephritic syndrome with diffuse membranous glomerulonephritis——
N02 - Recurrent and persistent hematuria——
N02.2 - Recurrent and persistent hematuria with diffuse membranous glomerulonephritis——
N02.8 - Recurrent and persistent hematuria with other morphologic changes——
N02.A - Recurrent and persistent hematuria with C3 glomerulonephritis——
N02.B3 - ——
N03 - Chronic nephritic syndrome——
N03.0 - Chronic nephritic syndrome with minor glomerular abnormality——
N03.2 - Chronic nephritic syndrome with diffuse membranous glomerulonephritis——
N03.3 - Chronic nephritic syndrome with diffuse mesangial proliferative glomerulonephritis——
N03.4 - Chronic nephritic syndrome with diffuse endocapillary proliferative glomerulonephritis——
N03.5 - Chronic nephritic syndrome with diffuse mesangiocapillary glomerulonephritis——
N03.7 - Chronic nephritic syndrome with diffuse crescentic glomerulonephritis——
N03.9 - Chronic nephritic syndrome with unspecified morphologic changes——
N03.A - Chronic nephritic syndrome with C3 glomerulonephritis——
N04 - Nephrotic syndrome——
N04.2 - Nephrotic syndrome with diffuse membranous glomerulonephritis——
N04.3 - Nephrotic syndrome with diffuse mesangial proliferative glomerulonephritis——
N04.8 - Nephrotic syndrome with other morphologic changes——
N04.9 - Nephrotic syndrome with unspecified morphologic changes——
N05 - Unspecified nephritic syndrome——
N05.2 - Unspecified nephritic syndrome with diffuse membranous glomerulonephritis——
N05.5 - Unspecified nephritic syndrome with diffuse mesangiocapillary glomerulonephritis——
N06 - Isolated proteinuria with specified morphological lesion——
N08 - Glomerular disorders in diseases classified elsewhere——
N13 - Obstructive and reflux uropathy——
N18 - Chronic kidney disease (CKD)——
N18.1 - Chronic kidney disease, stage 1——
N18.6 - End stage renal disease——
N18.9 - Chronic kidney disease, unspecified——
N23 - Unspecified renal colic——
N26 - Unspecified contracted kidney——
N26.9 - Renal sclerosis, unspecified——
N98.3 - Complications of attempted introduction of embryo in embryo transfer——
O09 - Supervision of high risk pregnancy——
O09.3 - Supervision of pregnancy with insufficient antenatal care——
O12 - Gestational [pregnancy-induced] edema and proteinuria without hypertension——
O23.9 - Unspecified genitourinary tract infection in pregnancy——
O23.90 - Unspecified genitourinary tract infection in pregnancy, unspecified trimester——
O23.91 - Unspecified genitourinary tract infection in pregnancy, first trimester——
O23.92 - Unspecified genitourinary tract infection in pregnancy, second trimester——
O23.93 - Unspecified genitourinary tract infection in pregnancy, third trimester——
O26 - Maternal care for other conditions predominantly related to pregnancy——
O28 - Abnormal findings on antenatal screening of mother——
O28.9 - Unspecified abnormal findings on antenatal screening of mother——
O35 - Maternal care for known or suspected fetal abnormality and damage——
O35.0 - Maternal care for (suspected) central nervous system malformation in fetus——
O36.01 - Maternal care for anti-D [Rh] antibodies——
O86.2 - Urinary tract infection following delivery——
O98.41 - Viral hepatitis complicating pregnancy——
O98.42 - Viral hepatitis complicating childbirth——
O99.01 - Anemia complicating pregnancy——
O99.280 - Endocrine, nutritional and metabolic diseases complicating pregnancy, unspecified trimester——
O99.810 - Abnormal glucose complicating pregnancy——
O99.814 - Abnormal glucose complicating childbirth——
O99.830 - Other infection carrier state complicating pregnancy——
P35.3 - Congenital viral hepatitis——
P58 - Neonatal jaundice due to other excessive hemolysis——
P59 - Neonatal jaundice from other and unspecified causes——
P59.0 - Neonatal jaundice associated with preterm delivery——
P59.9 - Neonatal jaundice, unspecified——
R05 - Cough——
R16 - Hepatomegaly and splenomegaly, not elsewhere classified——
R17 - Unspecified jaundice——
R18 - Ascites——
R18.8 - Other ascites——
R19 - Other symptoms and signs involving the digestive system and abdomen——
R19.0 - Intra-abdominal and pelvic swelling, mass and lump——
R43.0 - Anosmia——
R74 - Abnormal serum enzyme levels——
R74.0 - Nonspecific elevation of levels of transaminase and lactic acid dehydrogenase [LDH]——
R74.01 - Elevation of levels of liver transaminase levels——
R77 - Other abnormalities of plasma proteins——
R78 - Findings of drugs and other substances, not normally found in blood——
R78.1 - Finding of opiate drug in blood——
R78.2 - Finding of cocaine in blood——
R78.4 - Finding of other drugs of addictive potential in blood——
R78.5 - Finding of other psychotropic drug in blood——
R79 - Other abnormal findings of blood chemistry——
R79.82 - Elevated C-reactive protein (CRP)——
R79.9 - Abnormal finding of blood chemistry, unspecified——
R80 - Proteinuria——
R94 - Abnormal results of function studies——
R94.4 - Abnormal results of kidney function studies——
R94.5 - Abnormal results of liver function studies——
R94.8 - Abnormal results of function studies of other organs and systems——
T38 - Poisoning by, adverse effect of and underdosing of hormones and their synthetic substitutes and antagonists, not elsewhere classified——
T39 - Poisoning by, adverse effect of and underdosing of nonopioid analgesics, antipyretics and antirheumatics——
T39.013 - Poisoning by aspirin, assault——
T39.094S - Poisoning by salicylates, undetermined, sequela——
T39.1 - Poisoning by, adverse effect of and underdosing of 4-Aminophenol derivatives——
T39.1X1 - Poisoning by 4-Aminophenol derivatives, accidental (unintentional)——
T39.1X2 - Poisoning by 4-Aminophenol derivatives, intentional self-harm——
T39.1X3 - Poisoning by 4-Aminophenol derivatives, assault——
T39.1X4 - Poisoning by 4-Aminophenol derivatives, undetermined——
T40 - Poisoning by, adverse effect of and underdosing of narcotics and psychodysleptics [hallucinogens]——
T40.0X - Poisoning by, adverse effect of and underdosing of opium——
T40.2X5 - Adverse effect of other opioids——
T42.4X5A - Adverse effect of benzodiazepines, initial encounter——
T86 - Complications of transplanted organs and tissue——
T86.4 - Complications of liver transplant——
T86.40 - Unspecified complication of liver transplant——
T86.41 - Liver transplant rejection——
T86.42 - Liver transplant failure——
T86.43 - Liver transplant infection——
T86.49 - Other complications of liver transplant——
Z00 - Encounter for general examination without complaint, suspected or reported diagnosis——
Z00.0 - Encounter for general adult medical examination——
Z00.00 - Encounter for general adult medical examination without abnormal findings——
Z00.01 - Encounter for general adult medical examination with abnormal findings——
Z00.8 - Encounter for other general examination——
Z01.41 - Encounter for routine gynecological examination——
Z01.411 - Encounter for gynecological examination (general) (routine) with abnormal findings——
Z01.83 - Encounter for blood typing——
Z01.84 - Encounter for antibody response examination——
Z02 - Encounter for administrative examination——
Z04 - Encounter for examination and observation for other reasons——
Z11.1 - Encounter for screening for respiratory tuberculosis——
Z11.3 - Encounter for screening for infections with a predominantly sexual mode of transmission——
Z11.4 - Encounter for screening for human immunodeficiency virus [HIV]——
Z11.5 - Encounter for screening for other viral diseases——
Z11.51 - Encounter for screening for human papillomavirus (HPV)——
Z11.59 - Encounter for screening for other viral diseases——
Z12.10 - Encounter for screening for malignant neoplasm of intestinal tract, unspecified——
Z13.1 - Encounter for screening for diabetes mellitus——
Z13.220 - Encounter for screening for lipoid disorders——
Z13.40 - Encounter for screening for unspecified developmental delays——
Z13.41 - Encounter for autism screening——
Z13.42 - Encounter for screening for global developmental delays (milestones)——
Z13.6 - Encounter for screening for cardiovascular disorders——
Z16 - Resistance to antimicrobial drugs——
Z16.33 - Resistance to antiviral drug(s)——
Z20 - Contact with and (suspected) exposure to communicable diseases——
Z20.5 - Contact with and (suspected) exposure to viral hepatitis——
Z22.5 - ——
Z22.50 - ——
Z22.51 - ——
Z22.52 - ——
Z22.59 - ——
Z30.014 - Encounter for initial prescription of intrauterine contraceptive device——
Z30.8 - Encounter for other contraceptive management——
Z31.430 - Encounter of female for testing for genetic disease carrier status for procreative management——
Z31.440 - Encounter of male for testing for genetic disease carrier status for procreative management——
Z31.441 - Encounter for testing of male partner of patient with recurrent pregnancy loss——
Z32.0 - Encounter for pregnancy test——
Z33 - Pregnant state——
Z34 - Encounter for supervision of normal pregnancy——
Z34.0 - Encounter for supervision of normal first pregnancy——
Z34.00 - Encounter for supervision of normal first pregnancy, unspecified trimester——
Z34.8 - Encounter for supervision of other normal pregnancy——
Z34.9 - Encounter for supervision of normal pregnancy, unspecified——
Z34.90 - Encounter for supervision of normal pregnancy, unspecified, unspecified trimester——
Z36 - Encounter for antenatal screening of mother——
Z36.0 - Encounter for antenatal screening for chromosomal anomalies——
Z36.4 - Encounter for antenatal screening for fetal growth retardation——
Z36.8 - Encounter for other antenatal screening——
Z48.23 - Encounter for aftercare following liver transplant——
Z51 - Encounter for other aftercare and medical care——
Z51.0 - Encounter for antineoplastic radiation therapy——
Z51.1 - Encounter for antineoplastic chemotherapy and immunotherapy——
Z51.11 - Encounter for antineoplastic chemotherapy——
Z51.12 - Encounter for antineoplastic immunotherapy——
Z51.81 - Encounter for therapeutic drug level monitoring——
Z67 - Blood type——
Z68 - Body mass index [BMI]——
Z71.5 - Drug abuse counseling and surveillance——
Z71.51 - Drug abuse counseling and surveillance of drug abuser——
Z71.52 - Counseling for family member of drug abuser——
Z77 - Other contact with and (suspected) exposures hazardous to health——
Z77.120 - Contact with and (suspected) exposure to mold (toxic)——
Z79 - Long term (current) drug therapy——
Z79.1 - Long term (current) use of non-steroidal anti-inflammatories (NSAID)——
Z79.52 - Long term (current) use of systemic steroids——
Z79.89 - Other long term (current) drug therapy——
Z79.890 - Hormone replacement therapy——
Z79.891 - Long term (current) use of opiate analgesic——
Z79.899 - Other long term (current) drug therapy——
Z84 - Family history of other conditions——
Z85 - Personal history of malignant neoplasm——
Z85.05 - Personal history of malignant neoplasm of liver——
Z85.09 - Personal history of malignant neoplasm of other digestive organs——
Z85.71 - Personal history of Hodgkin lymphoma——
Z85.72 - Personal history of non-Hodgkin lymphomas——
Z86.11 - Personal history of tuberculosis——
Z87.798 - Personal history of other (corrected) congenital malformations——
Z94.4 - Liver transplant status——